Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pentostatin

Next Previous
X
Search
Drug Profile

Pentostatin

Alternative Names: 2'-Deoxycoformycin; CI 825; Coforin; DCF; Deoxycoformycin; Nipent; Nipentin; NSC 218321; Oncopent; PD 81565; YK 176

Latest Information Update: 16 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Cancer Institute (USA); Pfizer
  • Developer Hospira; National Cancer Institute (USA); Pfizer
  • Class Antineoplastics; Deoxyribonucleosides; Pyrimidine nucleosides; Small molecules
  • Mechanism of Action Adenosine deaminase inhibitors; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cutaneous T-cell lymphoma; Chronic lymphocytic leukaemia; Hairy cell leukaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Hairy cell leukaemia
  • No development reported Cutaneous T-cell lymphoma
  • Discontinued Graft-versus-host disease; Non-Hodgkin's lymphoma; Rheumatoid arthritis

Most Recent Events

  • 03 Sep 2015 Hospira has been acquired by Pfizer
  • 11 Oct 2013 Astex Pharmaceuticals has been acquired by Otsuka Pharmaceutical
  • 10 Aug 2010 Pentostatin is still in phase III trials for Chronic lymphocytic leukaemia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top